发明名称 |
CRYSTALLINE FORMS OF 3-[5-(2-FHJOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOIC ACID |
摘要 |
The present invention relates to preparation processes for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms comprising the crystalline forms, methods of making the crystalline forms and methods for their use for the treatment, prevention or management of diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay. |
申请公布号 |
EP2076501(B1) |
申请公布日期 |
2015.12.02 |
申请号 |
EP20070838770 |
申请日期 |
2007.09.24 |
申请人 |
PTC THERAPEUTICS, INC. |
发明人 |
ALMSTEAD, NEIL G.;HWANG, PETER SEONGWOO;MOON, YOUNG-CHOON |
分类号 |
C07D271/06;A61K31/4245 |
主分类号 |
C07D271/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|